Skip to content
Screener

Icahn Enterprises IEP Pharma — Goodwill Gross

Other segment segments

Automotive
$337M0.0%
Energy
$130M-12.8%
Home Fashion
$23M-4.2%
Food Packaging
$6M0.0%

Similar metrics at other companies

AeroVironment logo
AVAVUxs — Goodwill Gross
$411.9M-0.1%
Eastman Kodak Company logo
KODKPrint — Goodwill Gross
$62M0.0%
Eastman Kodak Company logo
KODKBrand — Goodwill Gross
$6M0.0%
Stepan logo
SCLPolymers — Goodwill Gross
$76.09M+8.1%
Stepan logo
SCLSurfactants — Goodwill Gross
$28.23M+6.6%
Inspired Entertainment logo
INSEVirtualsports — Goodwill Gross
$44M-1.8%

Other financials

Income statement

See full
Revenue$3.0B+25.6%
Net income-$355.0M-115%
EPS (diluted)-$0.52-73.3%

Balance sheet

See full
Cash & equivalents$1.2B-32.3%
Total debt$6.9B-5.2%
Total assets$12.9B-13.1%

Cash flow

See full
Operating cash flow$116.0M-57.8%
CapEx$80.0M-16.7%
Free cash flow$36.0M—

Valuation

See full
Market cap$5.42B+2.3%
Enterprise value$11.13B+3.0%
P/S0.5×0.0×

Profitability

See full
Gross margin-56.5%—
Net margin-5%-1.1pp
FCF margin-2.3%—

Returns & leverage

See full
Return on equity-0.1%—
Debt / equity0.7×—

Where this comes from

Reported directly by Icahn Enterprises in its filing.

Tagged under the XBRL concept us-gaap:GoodwillGross.

The source filing: Icahn Enterprises’s 10-Q, filed August 5, 2026.

Filed
Aug 4, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-090605
Line itemJune 30, 2026 / Gross / Carrying / AmountJune 30, 2026 / Accumulated / ImpairmentJune 30, 2026 / Net / Carrying / ValueDecember 31, 2025 / Gross / Carrying / AmountDecember 31, 2025 / Accumulated / ImpairmentDecember 31, 2025 / Net / Carrying / Value
Automotive$337$(87)$250$337$(87)$250
Food Packaging6—66—6
Home Fashion23(3)2024(3)21
Pharma13—1313—13
$379$(90)$289$380$(90)$290

Item 1. Financial Statements (Unaudited)

FAQ

What is Icahn Enterprises's pharma — goodwill gross?
Icahn Enterprises (IEP) reported pharma — goodwill gross of $13M in Q2 2026.
How has Icahn Enterprises's pharma — goodwill gross changed year-over-year?
Icahn Enterprises's pharma — goodwill gross decreased by 0.0% year-over-year, from $13M to $13M.
What is the long-term trend for Icahn Enterprises's pharma — goodwill gross?
Over 4 years (2021 to 2025), Icahn Enterprises's pharma — goodwill gross has grown at a 0.0% compound annual growth rate (CAGR), from $52M to $52M.
What does pharma — goodwill gross mean?
The total acquisition cost assigned to the pharmaceutical segment that exceeds the fair value of identifiable net assets. It represents the initial premium paid for intangible assets such as brand reputation, intellectual property, and market presence before any accumulated impairment.

Ask your AI about Icahn Enterprises's pharma — goodwill gross.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude